Latest News
Verrica Pharmaceuticals Inc.
- Verrica Pharmaceuticals Inc. Estimates – SWB:1NE0
- Verrica reports USD 5.86 million revenue. Target for Verrica Pharmaceuticals stock is USD 12.67
- Lake Street sets USD 9.00 target for Verrica Pharmaceuticals stock
- Lake Street keeps Buy rating for Verrica Pharmaceuticals stock
- Verrica Pharmaceuticals Q2 2026 Earnings Call Transcript
- Verrica Pharmaceuticals Q2FY26 Results: Revenue $5.9M, Net loss $13.2M
- Verrica Analysis Shows Faster Clearance With YCANTH
- Verrica Pharmaceuticals to Present New YCANTH® Data Analysis at Two Upcoming Dermatology Conferences
Headlines from the last 30 days, linking to the original publishers. See all market news →